verified SJR 0,281 · Q3 • database Scopus / SJR & Web of Science indexed

United States · Current Science, Inc.

workspace_premium Q3 — Oncology lock_open Open Access

Current Breast Cancer Reports

Current Breast Cancer Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elu...

ISSN: 1943-4588

Publisher: Current Science, Inc.

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Visit publisher site menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,281 Q3

H-index 27

Acceptance rate pie_chart

41%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.590 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,281

H-index

Docs (year)

Docs 3y

117

Total refs

3002

Cites 3y

105

Citable 3y

116

Cites/Doc 2y

0.97

Ref/Doc

62.54

Immediate OA

2590 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Bridging the Gap in Training and Clinical Practice in Sub-Saharan Africa

Who Benefits from Nodal Field Irradiation?

Endocrine Therapy Plus Zoledronic Acid in Premenopausal Breast Cancer: Review of a Clinical Trial

Endocrine Therapy for Metastatic Disease: Reversing Resistance

Emerging Prognostic and Predictive Biomarkers for Triple Negative Breast Cancer

Eliminating Surgery in Early-Stage Breast Cancer: Pipe-Dream or Worthy Consideration in Selected Patients?

Early Diagnosis of Breast Cancer in the Absence of Population-Based Mammographic Screening in Asia

Ductal Carcinoma In Situ (DCIS): the Importance of Patient-Reported Outcomes (PRO)

Cryoablation as a Replacement for Surgical Resection in Early Stage Breast Cancer

Correction to: A Radiation Oncologist's Guide to Axillary Management in Breast Cancer: a Walk Through the Trials

Coping With Advanced Breast Cancer

Circulating Tumour Cells as Liquid Biopsy in Breast Cancer - Advancing from Prognostic to Predictive Potential

SHOW MORE ARTICLES

Chemotherapy in Patients with Anthracycline and Taxane-Pretreated Metastatic Breast Cancer: An Overview

Adjuvant Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer in Premenopausal Patient: Understanding the Data

Breast Preservation in Patients with Local Recurrence After Breast-Conserving Therapy

Breast Cancer Treatment in Resource Constrained Countries: a Zimbabwean Perspective

Breast Atypia as a Biomarker of Risk

Bone Disease in Breast Cancer: The Era of New Targeted Therapies

Biomarkers and Therapeutic Targets in Inflammatory Breast Cancer (IBC)

Axillary Node Management in Patients Receiving Neoadjuvant Chemotherapy

Axillary Dissection in Women with Invasive Breast Cancer and Sentinel Node Metastasis

Antiangiogenesis Therapy in Breast Cancer

Advances in endocrine therapy and its implications for translational research

Advances in clinical trial designs for predictive biomarker discovery and validation

FAQs

Current Breast Cancer Reports has an SJR of 0,281 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is 2590 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Current Breast Cancer Reports is 41%.

Current Breast Cancer Reports

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Current Breast Cancer Reports?

What is the APC / publication cost?

What is the acceptance rate?